| 000 | 01639 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515220810.0 | ||
| 264 | 0 | _c20100927 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2010.03.050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRode, Frederik | |
| 245 | 0 | 0 |
_aFunctional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJul 2010 |
||
| 300 |
_a121-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthracenes _xpharmacology |
| 650 | 0 | 4 |
_aAnticonvulsants _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCarbachol _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCarbamates _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aKCNQ Potassium Channels _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aPhenylenediamines _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Chloride _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aUrinary Bladder _xdrug effects |
| 700 | 1 | _aSvalø, Julie | |
| 700 | 1 | _aSheykhzade, Majid | |
| 700 | 1 | _aRønn, Lars Christian B | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 638 _gno. 1-3 _gp. 121-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2010.03.050 _zAvailable from publisher's website |
| 999 |
_c19744132 _d19744132 |
||